4Gorzer I, Ke1chner H, Redlberger-Fritz M, et al. Human cyto- megalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection [ J ]. J Clin Viral, 2010, 48(2) : 100-103.
5Rossini G, Cerboni C, Santoni A, et al. Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bi- directional relationship [ J ]. Mediators Inflamm, 2012, 2012 : p. 607276.
6Kamar N, Mengelle C, Yahyaoui S, et al. Follow-up of 28 HCMV seropositive renal-transplant recipients : comparison of clinical, bi- ological and virological parameters in the groups of treated versus untreated infected patients[ J]. J Clin Virol, 2005, 33 ( 1 ) : 35- 42.
7Atkinson C, Emery VC. Cytomegalovirus quantification: where to next in optimising patient management? [ J ]. J Clin Virol, 2011, 51(4) : 223-228.
8Gerna G, Revello MG, Percivalle E, et al. Comparison of differ- ent immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein ( pp65 ) for optimal quantitation of hu- man cytomegalovirus antigenemia[ J]. J Clin Microbial, 1992, 30 (5) : 1232-1237.
9Ljungman P, Grifflths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients[ J]. Clin Infect Dis, 2002, 34(8) : 1094-1097.
10Sandin RL, Rodriguez ER, Rosenberg E, et al. Comparison of sensitivity for human eytomegalovirus of the polymerase chain re- action, traditional tube culture and shell vial assay by sequential dilutions of infected cell lines[ J]. J Virol Methods, 1991, 32 (2-3): 181-191.
4Jun KW,Park KM,Kim MH,et al.Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation[J].Ann Surg Treat Res,2014,87(1):28-34.
5Yany CW,Kim YO,Kin YS,et al.Clinical cou rse of cyt on egalovirus with and with ou t gancicl ovi r treatment in CMV-seroposit ive kidney Transpl ant[J].Am J Nephrol,1998,18(5):373-378.
6Seheffler S, Trautmann S, Smith M, et al. No influence of col- lagenous proteins of Achilles tendon, skin and cartilage on the vi- rus-inactivating efficacy of peracetie acid-ethanol [ J]. Biolo- gieals, 2007, 35(4): 355-356.
7Koivunen J, Heinonen H, Tanski. Peracetic acid (PAA) disin- fection of primary, secondary and tertiary treated municipal wastewaters[J]. Water Research, 2005, 39( 11 ) : 4445-4453.
8Nguyen H, Morgan DA, Forwood MR. Sterilization of allograft bone:effects of gamma irradiation on allograft biology and biome- chanics[J]. Cell Tissue Bank, 2007, 8(2) : 93-94.
9Hertoghs KM, Moerland PD, van Stijn A, et al. Molecular profi- ling of cytomegalovirus - induced human CD8 ~ T cell differentia-tion[ J]. J Clin Invest, 2010, 120(11) : 4077 - 4090.
10Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA - A alleles and infectious mononucleosis suggest a critical role for cytotoxic T - cell response in EBV -related Hodgkin lymphoma[ J]. Proc Natl Acad Sci USA, 2010, 107(14) : 6400 - 6405.
